Dg. Haxby et al., MANUFACTURERS DISTRIBUTION OF DRUG SAMPLES TO A FAMILY MEDICINE CLINIC, American journal of health-system pharmacy, 52(5), 1995, pp. 496-499
The distribution of drug product samples by pharmaceutical companies t
o a family medicine clinic was studied. Data on all deliveries of drug
samples to the clinic site of a university-affiliate family medicine
residency program from November 1992 through December 1993 were collec
ted. In addition, the 11 faculty family physicians were surveyed about
their experiences with the deliveries of samples. Forty-three manufac
turers delivered samples of 331 drugs during the 14-month study period
. There were 366 visits by the drug company representatives, who made
1117 separate deliveries. The total value of the samples, based on the
average wholesale price, was $240,782. Twenty-nine percent of the dru
gs were nonformulary and only 49% were stocked by the pharmacy. The ph
ysicians surveyed indicated that they were either usually or always as
ked to sign for samples they did not in fact request, that they usuall
y did not know what was recorded on the receipts for samples that they
signed, and that they seldom verified what was actually delivered. Ph
armaceutical manufacturers delivered large quantities of drug samples
during the study period, and many of the drugs were nonformulary or no
t stocked by the pharmacy. The physicians indicated that they were not
well informed about delivered samples for which they signed receipts.